Source: Eur Respir J 2008; 32: 862-870
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Geudens N., Van de Wouwer M., Vanaudenaerde B. M., Vos R., Van De Wauwer C., Verleden G. M., Verbeken E., Lerut T., Van Raemdonck D. E. M., Conway E. M.. The lectin-like domain of thrombomodulin protects against ischaemia-reperfusion lung injury. Eur Respir J 2008; 32: 862-870

Member's Comments

No comment yet.

Related content which might interest you: The lectin-like domain of thrombomodulin supresses leukocyte lung infiltration in a murine ischemia-reperfusion injury model Source: Eur Respir J 2006; 28: Suppl. 50, 779s Year: 2006 Gabexate mesilate attenuates ischemia-reperfusion injury of lung grafts via the inhibition of neutrophil activation Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005 Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006 Human protein C concentrate administration reduces inflammation and apoptosis in lung after experimental sepsis Source: Eur Respir J 2005; 26: Suppl. 49, 461s Year: 2005 Activated protein C protection in endotoxin-induced lung injury is mediated by lung matrix metalloproteinases activity Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007 Desferrioxamine attenuates minor lung injury following surgical acute liver failure Source: Eur Respir J 2009; 33: 1429-1436 Year: 2009 Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation Source: Eur Respir J 2007; 30: 423-428 Year: 2007 Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1 Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury Source: Eur Respir J 2013; 41: 165-176 Year: 2013 Post-treatment with the heat shock protein 90 (hsp90) inhibitor, AUY-922, reduces lung hsp90 tyrosine (Y) phosphorylation and pulmonary inflammation in LPS-induced acute lung injury (ALI) in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Kallistatin protects against LPS-induced mouse lung injury Source: Annual Congress 2012 - The many roads to lung injury Year: 2012 Transgenic mice expressing a surfactant protein-B-urokinase-fusion protein in the distal respiratory epithelium show an attenuated fibrotic response to bleomycin-induced lung injury Source: Annual Congress 2005 - In vivo - approaches to lung injury Year: 2005 Beneficial effects of synthetic KL4 surfactant in experimental lung transplantation Source: Eur Respir J 2011; 37: 925-932 Year: 2011 Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury Source: Eur Respir J 2009; 33: 1415-1428 Year: 2009 Inhaled activated protein C protects mice from ventilator-induced lung injury Source: Annual Congress 2009 - Acute lung injury: biological mechanisms Year: 2009 Dose-response of the lectin-like domain of TNF on lung oedema and lung mechanics in isolated rat lungs subjected to LPS-induced lung injury Source: Eur Respir J 2006; 28: Suppl. 50, 348s Year: 2006 Intermedin stabilized endothelial barrier function and attenuated ventilator-induced lung injury in mice Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 Endothelial- but not leukocytic-NOX2 mediates vascular injury in ischemia/reperfusion syndrome of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 822s Year: 2006 Bone morphogenetic protein 9 protects against neonatal hyperoxia-induced impairment of lung development, inflammation and fibrosis. Source: International Congress 2017 – Molecular pathways in lung development Year: 2017 A role for PAR1 in lipopolysaccharide induced acute lung injury Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008